Eli Lilly’s (LLY) Alzheimer’s Drug Is Rejected in Europe Over Safety Fears
A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible ...
European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
Billionaires Stanley Druckenmiller, Chase Coleman, and Stephen Mandel Jr. Are Piling Into This Growth Stock That's Beating the S&P 500
Each one of their moves may not be right for your particular investment strategy, but you may find certain ones that offer ...
Trump tariff threats prompt some drugmakers to expedite shipments to US
Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of ...
Healio1d
FDA recap: First new treatment for stroke in 3 decades, generic rivaroxaban and more
The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025
Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...
ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Here’s why Hims & Hers stock price has crashed: buy the dip?
Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.
Macau Business2d
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2025 AACR Annual Meeting
Innovent and Ascentage Pharma (6855.HK) reached the agreement regarding the joint development and commercialization of olverembatinib in China. Dr. Kaijie He, Vice President of Innovent, stated: “With ...
8 AI Drug Discovery and Manufacturing Stocks to Buy
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Breakthrough Drug Cuts Alzheimer’s Risk by 50% in High-Risk Patients
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
Mounjaro: Here Is How Eli Lilly Shares Have Performed Since The Launch Its Own 'Ozempic'
Now, Eli Lilly, the largest pharmaceutical company in the world in terms of market capitalisation, has launched its own ...